FAM149A Inhibitors
The chemical inhibitors targeting FAM149A function through a variety of mechanisms, each engaging distinct signaling pathways that indirectly lead to the inhibition of FAM149A. For instance, Rapamycin and LY294002 work by inhibiting the mTOR and PI3K/AKT/mTOR pathways, respectively. These are critical regulators of cell growth and proliferation, and since FAM149A may be associated with these cellular processes, the inhibition of these pathways by these compounds likely results in the downregulation of FAM149A activity. Conversely, PD98059, GW5074, and U0126 are inhibitors that specifically target components of the MAPK/ERK pathway. By inhibiting MEK enzymes, these compounds may reduce FAM149A activity by limiting its phosphorylation state and subsequent cellular functions, assuming FAM149A is a downstream effector in this signaling cascade.
In the same vein, SP600125 and SB203580 target the JNK and p38 MAPK signaling pathways, respectively. These pathways are integral to cellular stress responses, and their inhibition could lead to the modulation of FAM149A activity, provided that FAM149A is involved in these pathways. Other inhibitors such as Y-27632, a ROCK inhibitor, and Dasatinib, which targets SRC family kinases, may impact FAM149A through their roles in cytoskeletal dynamics and in various growth and survival signaling pathways. Furthermore, WZ4002 acts as an EGFR inhibitor and could influence FAM149A activity by dampening EGFR signaling, while Wortmannin and Ibrutinib, through their inhibition of PI3K and BTK, respectively, might also decrease FAM149A activity by altering associated signaling pathways. These inhibitors collectively provide a comprehensive approach to diminishing the functional activity of FAM149A by targeting the intricate network of pathways that regulate its activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor which suppresses cell growth and proliferation. Since FAM149A is involved in cellular processes that may include growth signaling, inhibition of mTOR can lead to reduced activity of FAM149A indirectly. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that impedes the PI3K/AKT/mTOR pathway. By blocking PI3K, this compound indirectly decreases the activation of downstream proteins, potentially including FAM149A, which could be affected by this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor which disrupts the MAPK/ERK pathway, a key signaling route that can regulate various proteins including FAM149A. Inhibition of MEK may lead to decreased phosphorylation and activity of FAM149A. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor, which by impeding the JNK signaling pathway could reduce the activity of proteins regulated by this pathway, potentially including FAM149A if it is part of or affected by JNK signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor which can decrease the activity of proteins that are regulated by p38 MAPK signaling. This may include FAM149A if its function is modulated by this pathway. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor that affects the actin cytoskeleton dynamics and cell motility. As FAM149A might be involved in cytoskeletal-associated processes, its activity could be indirectly inhibited by altering ROCK signaling. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
GW5074 is a Raf-1 inhibitor which can interfere with the MAPK/ERK signaling pathway. Through this action, it might indirectly affect the activity of FAM149A, particularly if FAM149A is regulated by the ERK pathway. | ||||||
WZ 4002 | 1213269-23-8 | sc-364655 sc-364655A | 10 mg 50 mg | $180.00 $744.00 | 1 | |
WZ4002 is an EGFR inhibitor that hinders the EGFR tyrosine kinase activity. If FAM149A activity is downstream of or influenced by EGFR signaling, its activity could be indirectly decreased by EGFR inhibition. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, key enzymes in the MAPK/ERK pathway. This inhibition could potentially lower the activity of FAM149A if it is influenced by or part of the regulation by the ERK signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3K inhibitor that can disrupt the PI3K/AKT signaling pathway. This disruption could lead to a decrease in FAM149A activity if it is modulated by or associated with PI3K/AKT signaling. | ||||||